FDA approves Mekinist in combination with Tafinlar for advanced melanoma
On Jan. 10, the U.S. Food and Drug Administration (FDA) announced it had approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients…
Oncology
Only 1 in 6 have discussed their alcohol use with a health professional
According to a report from the Centers for Disease Control and Prevention (CDC) only 1 in 6 adults have discussed their alcohol use with…
Study: Incidence of mental disorders in mid-life, older adulthood may be underestimated
A study published in JAMA Psychiatry has found that common methods of assessing mental or physical disorders may consistently underestimate the prevalence of mental…
Guiding your patients through menopause
The more you know about menopause, the more you can help patients understand and cope with symptoms.
Healthcare reform: Resolve to increase your knowledge in 2014
Find out how the Affordable Care Act is reforming health care and how it could affect your practice.
Study: Roles and responsibilities of patient navigators defined
A study in the Journal of Oncology Navigation and Survivorship defines the roles and responsibilities of patient navigators. Read more.
From our readers: My first code—A retrospective report of a premature promotion and a crisis situation
The elevator’s walls were covered in bronze and silver raised metal squares that gave the appearance of a magic eye puzzle and smelled of…
Nursing leaders hold the key to translating genomics into practice
A survey of attitudes, knowledge and genomic competency
Preventing complications in patients receiving opioids
Understand the terms opioid tolerant and opioid naïve so you can safely administer opioids and protect patients.
Detecting, managing, and preventing pulmonary embolism
Pulmonary embolism (PE) kills about 25% of those it strikes. This article explains how deep vein thrombosis (DVT) sets the stage for PE and…
FDA approves Gazyva for chronic lymphocytic leukemia
On Nov. 1, the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients with previously…
FDA approves Mekinist in combination with Tafinlar for advanced melanoma
On Jan. 10, the U.S. Food and Drug Administration (FDA) announced it had approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to…
Only 1 in 6 have discussed their alcohol use with a health professional
According to a report from the Centers for Disease Control and Prevention (CDC) only 1 in 6 adults have discussed their alcohol…
Study: Incidence of mental disorders in mid-life, older adulthood may be underestimated
A study published in JAMA Psychiatry has found that common methods of assessing mental or physical disorders may consistently underestimate the prevalence…
Guiding your patients through menopause
The more you know about menopause, the more you can help patients understand and cope with symptoms.
Healthcare reform: Resolve to increase your knowledge in 2014
Find out how the Affordable Care Act is reforming health care and how it could affect your practice.
Study: Roles and responsibilities of patient navigators defined
A study in the Journal of Oncology Navigation and Survivorship defines the roles and responsibilities of patient navigators. Read more.
From our readers: My first code—A retrospective report of a premature promotion and a crisis situation
The elevator’s walls were covered in bronze and silver raised metal squares that gave the appearance of a magic eye puzzle and…
Nursing leaders hold the key to translating genomics into practice
A survey of attitudes, knowledge and genomic competency
Preventing complications in patients receiving opioids
Understand the terms opioid tolerant and opioid naïve so you can safely administer opioids and protect patients.
Detecting, managing, and preventing pulmonary embolism
Pulmonary embolism (PE) kills about 25% of those it strikes. This article explains how deep vein thrombosis (DVT) sets the stage for…
FDA approves Gazyva for chronic lymphocytic leukemia
On Nov. 1, the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients…